首页> 外文OA文献 >Immune Monitoring of Cancer Patients Prior to and During CTLA-4 or PD-1/PD-L1 Inhibitor Treatment

【2h】

Immune Monitoring of Cancer Patients Prior to and During CTLA-4 or PD-1/PD-L1 Inhibitor Treatment

机译：CTLA-4或PD-1 / PD-L1抑制剂治疗前和癌症患者的免疫监测

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Antje Tunger; Maximilian Kießler; Rebekka Wehner; Achim Temme; Friedegund Meier; Michael Bachmann; Marc Schmitz;
展开▼
作者单位

展开▼
年度 2018
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Immune Monitoring of Cancer Patients Prior to and During CTLA-4 or PD-1/PD-L1 Inhibitor Treatment [J] . Antje Tunger, Maximilian Kie?ler, Rebekka Wehner, Biomedicines . 2018,第1期

机译：癌症患者在CTLA-4或PD-1 / PD-L1抑制剂治疗之前和期间的免疫监测
2. Correction: Comprehensive Meta-analysis of Key Immune-Related Adverse Events from CTLA-4 and PD-1/PD-L1 Inhibitors in Cancer Patients [J] . Cancer immunity . 2018,第4期

机译：校正：癌症患者中来自CTLA-4和PD-1 / PD-L1抑制剂的关键免疫相关不良事件的综合Meta分析
3. Comprehensive Meta-analysis of Key Immune-Related Adverse Events from CTLA-4 and PD-1/PD-L1 Inhibitors in Cancer Patients (vol 5, pg 312, 2017) [J] . de Velasco G., Je Y., Bosse D., Cancer immunology research. . 2018,第4期

机译：癌症患者中CTLA-4和PD-1 / PD-L1抑制剂的关键免疫相关不良事件综合荟萃分析（Vol 5，PG 312,2017）
4. Who Bridged the "Valley of Death" Between Basic Research and Clinical Research? In the Case of Immune-Checkpoints CTLA-4 and PD-1 Based on Inter-Citation Network [C] . Qiuju Zhou, Guilin Meng, Ying Ding Annual Meeting of the Association for Information Science and Technology . 2019

机译：谁在基础研究和临床研究之间桥梁“死亡”？在基于引文中的免疫检查点CTLA-4和PD-1的情况下
5. Immune Checkpoints PD-1/PD-L1 and Natural Killer Cells in Chemo-resistant Colorectal Cancer [D] . Siu, Hon Lam Elaine. 2019

机译：免疫检查点PD-1 / PD-L1和化疗结直肠癌中的天然杀伤细胞
6. Immune Monitoring of Cancer Patients Prior to and During CTLA-4 or PD-1/PD-L1 Inhibitor Treatment [O] . Antje Tunger, Maximilian Kießler, Rebekka Wehner, 2018

机译：在CTLA-4或PD-1 / PD-L1抑制剂治疗之前和期间对癌症患者的免疫监测
7. Comprehensive Meta-analysis of Key Immune-Related Adverse Events from CTLA-4 and PD-1/PD-L1 Inhibitors in Cancer Patients [O] . Guillermo De Velasco, Youjin Je, Dominick Bossé, 2017

机译：癌症患者中CTLA-4和PD-1 / PD-L1抑制剂的关键免疫相关不良事件的综合荟萃分析

Immune Monitoring of Cancer Patients Prior to and During CTLA-4 or PD-1/PD-L1 Inhibitor Treatment

著录项

引文网络

相似文献

相关主题

期刊订阅